Analysts Set Cardlytics, Inc. (NASDAQ:CDLX) Target Price at $6.42

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have earned a consensus rating of “Hold” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $6.42.

Several equities analysts have weighed in on the company. Lake Street Capital reduced their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating for the company in a report on Thursday, March 13th. Evercore ISI cut their price target on Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th.

Cardlytics Stock Down 1.0 %

Cardlytics stock opened at $2.01 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a market capitalization of $104.69 million, a P/E ratio of -0.33 and a beta of 1.62. The firm has a 50 day moving average price of $2.84 and a 200-day moving average price of $3.40. Cardlytics has a twelve month low of $1.77 and a twelve month high of $15.89.

Insider Activity at Cardlytics

In related news, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the transaction, the chief executive officer now owns 418,637 shares of the company’s stock, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cardlytics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. RBF Capital LLC raised its holdings in shares of Cardlytics by 311.9% in the 3rd quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after acquiring an additional 369,620 shares in the last quarter. Geode Capital Management LLC raised its stake in Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after purchasing an additional 73,484 shares in the last quarter. Barclays PLC lifted its position in Cardlytics by 223.9% during the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares during the last quarter. SG Americas Securities LLC lifted its position in Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after purchasing an additional 5,392 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Cardlytics in the 3rd quarter worth approximately $153,000. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.